Evidence map›Paper›PMID 39561975›Full record

ArticleJournal of inherited metabolic disease2025

Brain morphometry in hepatic Wilson disease patients.

Parya Rahimi, Stanislav Mareček, Radan Brůha, Monika Dezortová, Petr Sojka, Milan Hájek, Marta Skowrońska, Łukasz Smoliński, Petr Urbánek, Tomasz Litwin and 1 more

Abstract read
In one paragraph

Article in Journal of inherited metabolic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Brain morphometry in hepatic Wilson disease patients.Journal of inherited metabolic disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Parya RahimiDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
Stanislav MarečekDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
Radan BrůhaFourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
Monika DezortováMR Unit, Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czechia.
Petr SojkaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
Milan HájekMR Unit, Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czechia.
Marta SkowrońskaSecond Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Łukasz SmolińskiSecond Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Petr UrbánekDepartment of Medicine, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czechia.
Tomasz LitwinSecond Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Petr DušekDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.ORCID 0000-0003-4877-9642

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy LX22NPO5107 (MEYS) - Financed by European Union - Next Generation EUMinisterstvo Zdravotnictví Ceské Republiky IN 00023001Ministerstvo Zdravotnictví Ceské Republiky MHCZ-DRO-VFN64165Ministerstvo Zdravotnictví Ceské Republiky NV15-25602A
6 · The paper itself

Abstract

Wilson disease (WD) primarily presents with hepatic and neurological symptoms. While hepatic symptoms typically precede the neurological manifestations, copper accumulates in the brain already in this patient group and leads to subclinical brain MRI abnormalities including T2 hyperintensities and atrophy. This study aimed to assess brain morphological changes in mild hepatic WD. WD patients without a history of neurologic symptoms and decompensated cirrhosis and control participants underwent brain MRI at 3T scanner including high-resolution T1-weighted images. A volumetric evaluation was conducted on the following brain regions: nucleus accumbens, caudate, pallidum, putamen, thalamus, amygdala, hippocampus, midbrain, pons, cerebellar gray matter, white matter (WM), and superior peduncle, using Freesurfer v7 software. Whole-brain analyses using voxel- and surface-based morphometry were performed using SPM12. Statistical comparisons utilized a general linear model adjusted for total intracranial volume, age, and sex. Twenty-six WD patients with mild hepatic form (30 ± 9 years [mean age ± SD]); 11 women; mean treatment duration 13 ± 12 (range 0-42) years and 28 healthy controls (33 ± 9 years; 15 women) were evaluated. Volumetric analysis revealed a significantly smaller pons volume and a trend for smaller midbrain and cerebellar WM in WD patients compared to controls. Whole-brain analysis revealed regions of reduced volume in the pons, cerebellar, and lobar WM in the WD group. No significant differences in gray matter density or cortical thickness were found. Myelin or WM in general seems vulnerable to low-level copper toxicity, with WM volume loss showing promise as a marker for assessing brain involvement in early WD stages.

Indexed as

BrainHepatolenticular DegenerationMagnetic Resonance ImagingAdultCase-Control StudiesFemaleGray MatterHumansLiverMaleMiddle AgedWhite MatterYoung Adultbrain atrophybrainstemhepaticmorphometryMRIwhite matterWilson disease

Identifiers

PMID39561975
PMCPMC11670153

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.